DCEG's Mission Statement
The Division of Cancer Epidemiology and Genetics (DCEG) is the world’s largest and leading cancer epidemiology research group. With its cadre of renowned epidemiologists, geneticists, and biostatisticians, DCEG conducts population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Division’s research impacts public health policy in the United States and around the world. Through its programs in cancer epidemiology, genetics, statistics, and related areas, the Division:
- Conducts broad-based, high quality, high impact research;
- Maintains a national and international perspective, giving priority to emergent issues identified through clinical, laboratory, and epidemiologic observations, as well as to public health concerns identified by the Institute, Congress, regulatory agencies, and other appropriate bodies;
- Develops infrastructures, resources, and strategic partnerships in molecular epidemiology across NCI, NIH, and the extramural community; and
- Trains the next generation of scientists in cancer epidemiology and related fields.
Organization Chart (pdf, 18kb)
Major areas of investigation include:
- Biostatistics
- Clinical Genetics
- Genetic Epidemiology
- Health Disparities
- Hormonal and Reproductive Epidemiology
- Infections and Immunoepidemiology
- Nutritional Epidemiology
- Occupational and Environmental Epidemiology
- Radiation Epidemiology
- Translational Genomics
DCEG is uniquely able to conduct epidemiology research projects that:
- Are high risk,
- Need long-term commitments of funding and scientific staff,
- Require a national programmatic approach,
- Need a quick response to emerging public health or scientific issues,
- Might go unattended by groups without a national and international reach, or
- Require an interdisciplinary approach that is fostered by the breadth and interactive potential of the intramural research program of NCI and NIH.
